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Past research suggests that use of psychedelic substances such as
LSD or psilocybin may have positive effects on mood and feelings
of social connectedness. These psychological effects are thought
to be highly sensitive to context, but robust and direct evidence
for them in a naturalistic setting is scarce. In a series of field studies
involving over 1,200 participants across six multiday mass gather-
ings in the United States and the United Kingdom, we investigated
the effects of psychedelic substance use on transformative expe-
rience, social connectedness, and positive mood. This approach
allowed us to test preregistered hypotheses with high ecological
validity and statistical precision. Controlling for a host of demo-
graphic variables and the use of other psychoactive substances,
we found that psychedelic substance use was significantly asso-
ciated with positive mood—an effect sequentially mediated by
self-reported transformative experience and increased social con-
nectedness. These effects were particularly pronounced for those
who had taken psychedelic substances within the last 24 h (com-
pared to the last week). Overall, this research provides robust
evidence for positive affective and social consequences of psyche-
delic substance use in naturalistic settings.
psychedelic substances | transformative experiences | social
connectedness | mood
Research into the therapeutic potential of psychedelic sub-stances (such as psilocybin, LSD, and mescaline) has come
into renewed focus after several decades of relatively scant at-
tention (1). Recent clinical studies attest to the relative safety
and tolerability of these substances (2), in terms of both physical
(3) and mental health (4), and contemporary research suggests
that serotonergic psychedelics can have a variety of decidedly
positive effects when used in therapeutic settings. Specifically,
clinical researchers have begun investigating the potential of
psychedelics in the treatment of mental health disorders, in-
cluding affective disorders (5), anxiety-related disorders (6), and
substance abuse disorders (7). For example, recent findings in-
dicate that a single dose of psilocybin, the primary active com-
ponent in mushrooms of the Psilocybe genus, can meaningfully
attenuate depressive symptoms in patients with treatment re-
sistant depression for up to 3 mo postadministration (5). Sim-
ilar studies have been conducted—or are ongoing—for other
serotonergic psychedelic substances such as LSD (8) or N,N-
dimethyltryptamine (found in ayahuasca) (9).
Researchers have also begun investigating the acute and
chronic effects of psychedelic substances on healthy individuals.
They found, for example, that serotonergic psychedelics admin-
istered in the laboratory have noticeable acute effects on the
affective processing of negative stimuli (10), feelings of social
exclusion (11), as well as moral (12) and social decision-making
(13). Other research endeavors have used large-scale surveys to
query members of the general public about their substance use
history and found that past psychedelic substance use positively
predicted mental well-being (4) and proenvironmental behavior
(14), while being negatively related to suicidality (4).
Yet, existing research on the psychological effects of psy-
chedelics has several important limitations. On one hand,
laboratory-based approaches, which allow for causal inferences
through randomization, typically suffer from low sample sizes
due to financial costs and logistical demands. In addition, they
can be affected by sampling bias, in that people may sign up for
a study with the explicit desire to have a psychedelic experience,
or fail to capture the effects of spontaneous substance use.
Laboratory settings also rarely resemble settings in which
people typically use psychedelic substances—an especially im-
portant limitation given that the effects of these substances are
notoriously affected by situational variables (2). The classic
notions of “set and setting” emphasize the degree to which
intrapersonal and environmental variables can affect the psy-
chedelic experience (15, 16). For this reason, while existing
laboratory research undoubtedly provides important insights
into the psychological consequences of psychedelic substance
use, this work leaves open the crucial question of how such
consequences manifest in naturalistic settings. Finally, despite
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being placebo-controlled, participants in laboratory studies are
aware of the fact they partake in a study investigating the ef-
fects of psychedelic substances, which may affect their re-
sponses to questionnaires or tasks due to preconceived notions
they might have about these substances.
On the other hand, large-scale survey studies, often obtained
via online sampling, are an efficient way to collect data from a
large number of participants about past psychedelic substance
use and its psychological consequences. However, interpretation
of these data is complicated by the fact that many participants in
these studies were not recently under the influence of the re-
spective substances at the time of data collection, thereby ren-
dering their reports subject to the vagaries of personal recollection
(since participants are often relying on memories of past experi-
ences), and are hence potentially unreliable. Research of this
nature also suffers from demand and suggestibility effects as
participants are again usually aware they are taking part in a study
about psychedelics. For these reasons, existing research represents
a valuable but incomplete picture of the psychological conse-
quences of psychedelic substance use.
The Present Research
We aimed to address these limitations by conducting a large-
scale field study involving more than 1,200 participants at six
multiday mass gatherings across the United States and the
United Kingdom. Substance use at mass gatherings such as music
and arts festivals is known to be a common occurrence (17, 18).
There are several advantages to our field study approach. First,
the large sample size afforded a greater degree of statistical
precision than that obtained in previous research. Second, be-
cause the investigation took place on site, it allowed us to test
participants within (on average) 72 h of substance consumption,
thereby enabling a more fine-grained analysis of the temporal
dynamics of psychedelic substance use while the experiences
were still salient. Specifically, comparing people who took psy-
chedelics at different points in time determines how the recency
of a psychedelic experience relates to its effects and further al-
lows us to rule out the possibility that any effect on our outcome
variables are explained by a general willingness to use psychedelics
(which may be confounded with personality traits and de-
mographics that separately predict those outcome variables). Fi-
nally, the recreational setting provided the opportunity to conduct
observations in a context more typical of substance use. Through
this method, we hoped to isolate the unique, acute psychological
effects of psychedelic substance use.
Our investigation focused on three key outcome variables. Our
primary question concerned whether psychedelic substance use
was associated with increased positive mood. This was based on
past findings suggesting that psychedelic substance use can elicit
pronounced and lasting changes in healthy individuals’ subjective
well-being (19), as well as clinical research indicating that single
doses of psilocybin can alleviate depressive symptoms of patients
whose condition was previously classified as treatment-resistant
(5). We therefore sought to confirm in our field sample the as-
sociation between psychedelic substance use and positive mood.
We further focused on two psychological processes that we
predicted would explain the relationship between psychedelic
substance use and positive mood. The first was people’s sense of
having had a transformative experience (TE). TEs, also called
self-transcendent (20) or quantum change (21) experiences, are
defined in philosophy as experiences characterized by an epi-
stemic shift that is so profound it causes a substantial change in
one’s personal values and priorities that is practically impossible
to accurately imagine in advance (22). Such profound changes to
a person’s values, beliefs, or morals may in turn result from a
mystical-type experience (23), a key element of the psychedelic
experience (24), that is characterized, for example, by feelings of
internal and external unity, transcendence of time and space, a
sense of awe or sacredness, and a distinct noetic quality per-
taining to one’s understanding of reality. For example, in a
placebo-controlled psilocybin study conducted in a laboratory
setting, 22 of 36 participants reported having had such an experi-
ence after taking psilocybin (23), which 21 participants considered
one of the top five most personally meaningful experiences in their
lives (25). These experiences have been found to produce lasting,
positive effects on subjective well-being (25), openness to experi-
ence (26), perceived meaning in life (25), and prosocial attitudes
and behaviors (19). Importantly, past research found the beneficial
effects of psychedelic substance use on subjective well-being
depended on the strength of mystical-type experience reported
by participants during the experimental sessions, with more pro-
nounced experiences predicting greater long-term positive out-
comes (27). Therefore, we predicted that people’s reported degree
of TE as a function of their use of psychedelics would be positively
associated with positive mood.
Second, we investigated people’s sense of connectedness to
others. Past research suggests that psychedelics often engender a
feeling of ego dissolution (24), a compromised sense of self most
likely attributable to attenuated neural connectivity in the brain’s
default mode network (28). The reduced activity in these brain
areas, known to be critical for accurate self-processing, is be-
lieved to be responsible for perceptually blurring the lines be-
tween self and outside world (29, 30), causing feelings of oceanic
boundlessness or external unity during the psychedelic state, and
thereby fostering a sense of connectedness with external objects
or entities (31). As put by one of the participants in Griffiths
et al.’s study, “[I experienced a] feeling of no boundaries, where I
didn’t know where I ended and where my surroundings began.
Somehow I was able to comprehend what oneness is” (ref. 25,
p. 629). In psychological terms, feelings of unity with other living
entities can be described as an increased inclusion of others in
the self—a self-construal incorporating other human beings that
is considered a crucial element of close relationships (32)—or a
heightened sense of social connectedness. Past studies found a
sense of social disconnectedness to be a key feature of depression
(33), while feelings of connectedness between oneself and others
were associated with reduced depressive symptoms (31). In the
domain of psychedelic research, it has therefore been theorized
that increases in social connectedness may be responsible for the
positive effects psilocybin use can have on mental well-being (34),
and it was empirically validated that psilocybin administration has
specific, dose-dependent effects on people’s tendency to incor-
porate others in their self-construal (19). Thus, we predicted that
greater degree of social connectedness would be associated with
more positive mood after substance use.
Overall, then, we tested whether recent psychedelic substance
use in naturalistic, nonclinical settings would predict positive
mood as a function of TEs and/or a heightened sense of con-
nectedness to other human beings.
Method
Participants and Design. Over the course of 3 y, we collected data from 1,242
attendees of six different multiday mass gatherings in the United States and
the United Kingdom (SI Appendix, SOM I, Table 1). Of those participants, 17
were excluded from data analyses for indicating on an attention/sobriety
check item embedded in the questionnaire that they have had one or
multiple fatal(!) heart attacks, leaving a final sample of 1,225 participants.*
All participants provided informed consent and completed a questionnaire
comprising several different scales, tasks, and demographic questions. Al-
though the questionnaires for the different events were for the most part
identical, certain tasks, scales, or items were added or modified over the
course of data collection (see footnotes †, ‡, and §). Participants were given
*Due to a data entry error, responses to the exclusion item are missing for 156 partici-
pants at event 2. Due to the generally low number of participants failing this check, we
decided to include these participants in our data analyses.





























the choice of several prizes preselected to be valuable to attendees (e.g.,
glow sticks, scarves, sunscreen, earplugs, and fans) as compensation for their
participation. To prevent repeat participation and incidental duplicate data
entries, as well as to allow for anonymized post hoc identification of a
participant’s data, we asked participants to provide an individual identifi-
cation code composed of the first three letters of the first road on which
they ever lived, the two-digit calendar day of their birthday, and the last two
letters of their mother’s maiden name. The research protocol was approved
by the University of Oxford Central University Research Ethics Committee
(MS-IDREC-C1-2015-134).
Materials and Procedure. Data were collected at events between 2015 and
2017 (35). For on-site data collection, teams of 5 to 10 experimenters
recruited attendees from a booth set up in well-trafficked areas with a sign
labeled “Play Games for Science.” After granting their consent, participants
either were handed a tablet computer to work on the survey (at events 4 to
6) or received a paper-and-pencil version of the questionnaires (at events
1 to 3).
Psychoactive substances. As our primary predictor variables for the present
analyses, we assessed people’s recent use of various psychoactive substances.
Specifically, we asked people to indicate whether they had taken any sub-
stance of a given class of psychoactive substances within the past 24 h or at
some point during the week prior. We further asked them whether they
were under the influence of any substance belonging to the respective class
when filling out the questionnaire, as well as whether they had taken
substances belonging to this class for the first time that week.
One challenge for assessing substance use in naturalistic settings is the
possibility that participants might refuse to answer questions about sub-
stance use affirmatively for fear of legal repercussions. To overcome this
challenge, for each class of substances in the survey, we made sure to include
one example of a legal substance (i.e., salvia, Kratom, hemp oil, or phar-
maceutical medications). This was made explicitly clear to participants in the
survey to reassure them that affirmative responses would not incriminate
them in any way.
Participants were asked to indicate their recent use of alcohol, nicotine,
cannabis products (e.g., weed, THC, CBD, and hemp oil), hallucinogens (e.g.,
psilocybin, LSD, salvia, mescaline, and DMT), euphorics (e.g., MDMA, Molly,
and Kratom), stimulants (e.g., cocaine, methamphetamine, and ephedrine),
narcotic analgesics (e.g., morphine, heroin, and oxycodone), benzodiazepines
(e.g., Valium and Alprazolam [Xanax]), inhalants (poppers, whip-its, nitrous
oxide, and glue), and other substances (SI Appendix, SOM IV).
Control variables. We preregistered a set of control variables, which we in-
cluded in all analyses performed with the present dataset. We selected these
covariates based on previous research that found that users and nonusers of
psychedelic substances significantly differ on certain demographic variables
(14, 36). We tried to include as many relevant demographic variables as
possible, without overfitting the models or reducing their interpretability.
As a result, we ultimately decided to control for participants’ age, gender
(male, female, or other/both/none; dummy-coded)†, educational attainment
(high school, some college, 2-y degree, 4-y degree, or postgraduate or
professional degree; dummy-coded), religious belief (on a seven-point
Likert-type scale ranging from not religious to very religious), and political
orientation (on a seven-point scale from extremely liberal to extremely
conservative).‡
TEs. As our first criterion, we assessed on a single seven-point Likert-type item
ranging from not at all to absolutely whether participants reported having
had a TE while attending the event (“Have you had a transformative
experience while at <event>?”).
Additionally, wewere interested inwhether participants had a special kind
of TE, referred to as an epistemically ET (ETE). Specifically, we gave partici-
pants a definition of ETEs based on Paul (22): “We are curious about a special
kind of transformative experience: an experience that changes you so pro-
foundly that you come out of the experience radically different than you
were before the experience. This transformation may have been so pro-
found that you could not have known what the experience or change would
be like before going through it” (SI Appendix, SOM IV). Following this de-
scription, we again asked participants to indicate whether they have had
such an experience using the same scale we used for the initial question
on TEs.
To gain more insight into these experiences, using seven-point Likert-type
scales, we then asked participants to indicate the extent of their TE (minimal
to complete), how good it felt (not at all to extremely), how bad it felt (not at
all to extremely), whether they expected such a transformation (not at all to
absolutely), whether they desired it (not at all to absolutely), and whether it
caused them to significantly change their moral values (not at all to abso-
lutely). We had no a priori hypotheses with regard to the quality of people’s
experiences. Yet we still decided to analyze people’s responses exploratorily,
in order to find out how the expectation and desire of having a TE factored
into their actual experience, as well as to gain insight into the nature of TEs
experienced as a result of substance use.
Similarly, for ETEs, we asked some participants whether they were glad
that they had this experience (not at all to very much) and whether this
experience affected their moral values (not at all to definitely). A subset of
participants provided answers about whether they expected (not at all to
definitely) or desired (not at all to definitely) an ETE.
Social connectedness. To assess this construct, we presented participants with a
modified version of the “inclusion of others in the self” scale—originally
designed to assess how strongly people include their romantic partners in
their self-construal. The scale comprises seven images, each displaying two
equally sized circles with varying degrees of overlap, ranging from full
separation of the two circles to nearly full overlap (32). For the present
purposes, the two circles were labeled “self” and “other.” Participants were
asked to “circle the image that best describes [their] current relationship
with other human beings, in general” (SI Appendix, SOM IV). As such, higher
values on this measure indicate greater social connectedness.
Positive mood. To test the hypothesis that recent use of psychedelic substances
would predict participants’ positive mood, we assessed people’s current af-
fective state using a single pictorial item (SI Appendix, SOM IV). Specifically,
participants were presented with six faces with different facial expressions,
ranging from a very joyful expression to a sad, crying expression. Participants
were asked to “circle the image that best represents [their] current mood.”
We coded this measure so that higher values indicate a more positive
affective state.
Preregistered hypotheses. Before analyzing the data, we preregistered a set of
hypotheses based on previous empirical findings and theoretical arguments
from the literature (https://osf.io/q8xvd). Specifically, among other hypotheses,
we predicted that recent use of psychedelic substances (i.e., during the past
24 h or during the past week) would positively predict self-reported TEs and
feelings of social connectedness. We further predicted a positive relationship
between psychedelic substance use and participants’ mood, mediated by their
reports of having had a TE. In other words, we hypothesized that recent use of
psychedelic substances would lead to a greater chance of having had a TE,
which should in turn positively predict participants’ affective state.
Past research has shown that use of various kinds of psychoactive sub-
stances is highly intercorrelated (14). In order to account for these inter-
correlations, for all of our hypothesis tests and exploratory analyses, we
predicted that use of psychedelic substances would predict the respective
outcome variables when statistically controlling for the use of all other types
of psychoactive substances assessed. This approach allowed us to investigate
the unique predictive power of psychedelic substance use regardless of
people’s general propensity to consume mind-altering substances or their
simultaneous use of other, nonpsychedelic substances.
Further, we specified in our preregistration that in addition to using
aggregate scores representing use of psychedelics at any point during the
week prior, wewould test our hypotheses by exclusively analyzing very recent
use of psychoactive substances (i.e., participants currently under the influence
or who used the substances in the last 24 h). Results for these analyses can be
found in SI Appendix, SOM I. Instead, we chose to include a more sophisti-
cated, nonpreregistered set of analyses in the main manuscript, in which we
disentangled whether very recent or moderately recent use of psychedelics
(i.e., during the week prior) would be more predictive of the outcome var-
iables, by simultaneously entering both variables into the respective regression
models. Likewise, we included a nonpreregistered structural equation model
to exploratorily consolidate our findings.
All data discussed in the paper are available at https://osf.io/avdrc.
Results
Sample Characteristics. The sample was mostly composed of youn-
ger (M = 32.39, SD = 11.37), educated adults (median educa-
tion: 4-y college degree), with low to medium levels of religiosity
(M = 2.31, SD = 1.63, on a seven-point scale), moderately liberal
†At event 1, participants indicated their gender on an open response item. Their re-
sponses were later coded to match the data collected at the other events.
‡At two events, event 1 and event 4, participants were asked two individual questions
about social and economic conservatism. To include data from these two events, we
merged the two variables to create a single liberalism–conservatism index; r(231) = 0.45,
P < 0.001.
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political views (M = 2.67, SD = 1.19, on a seven-point scale)
(Table 1), and a median annual income of $26,000 to $35,000.
With regard to the use of psychoactive substances among the
attendees, we found that use of alcohol was the most widespread
(80.0% of all attendees), followed by cannabis products (50.9%)
and nicotine (35.9%). Psychedelic substances were used by
26.6% of the sample, with similar values for euphorics (24.8%)
and stimulants (21.6%). Substances from the remaining clas-
ses were all used to a substantially lesser degree (≤7.1% each;
Fig. 1); 12.3% of all attendees reported having taken no
substance.
Statistical Analyses. We used the lavaan package (version 0.5-
23.1097; ref. 37) for R to run our regression analyses. In all
models, parameter estimates were obtained through normal
maximum likelihood estimation (using the biased sample co-
variance matrix), with SEs based on the observed information
matrices. Missing values were estimated using a full information
maximum likelihood procedure (38). In all analyses, we regressed
the outcome variables on all variables representing use of a certain
class of psychoactive substance as well as on all control variables.
Deviations from this approach are noted.
For each class of psychoactive substance, we created a binary
score indicating whether participants used any of the included
substances throughout the past week. Participants who reported
having taken a substance in the last 24 h or during the week prior
or who were currently under the influence of the substance were
coded 1, while the remaining participants were coded 0. In each
analysis, we predicted the outcome variable with all substance
classes and covariates.
Prediction of Individual Outcome Variables: (Epistemically) TEs, Positive
Mood, and Social Connectedness.
TEs. As hypothesized, use of psychedelic substance positively
predicted TEs: b = 0.79 (β = 0.17), SE = 0.15, P < 0.001, 95%
CI = [0.49; 1.09]. Thus, people who recently took psychedelic
substances were indeed more likely to report having had a TE
than were people who did not take any of these substances,
regardless of their use of other psychoactive substances or
associated demographic variables.
There remains, however, the possibility that people who
planned on using psychedelics at the respective events had a
greater desire to have a TE or were more likely to expect having
such an experience. As such, it could be the case that these de-
sires were partly responsible for having a TE in the first place (in
that people were more open to experiencing transformation or
more likely to seek out situations that would enable trans-
formation; cf. a self-fulfilling prophecy (39)) or that expectations
and desires caused participants to retroactively conceptualize
certain experiences as being transformative (cf. confirmation bias
(40)). However, entering both desire for and expectations about
TEs into the model speaks against this possibility. While both
desires, b = 0.23 (β = 0.23), SE = 0.04, P < 0.001, 95% CI =
[0.15; 0.30], and expectations, b = 0.17 (β = 0.15), SE = 0.04, P <
0.001, 95% CI = [0.09; 0.24], predicted self-reported TEs, use of
psychedelics still predicted TEs over and above these effects: b =
0.67 (β = 0.14), SE = 0.14, P < 0.001, 95% CI = [0.39; 0.95].
ETEs. Having an ETE was a more rare occurrence (M = 2.79,
SD = 1.97) than having an unspecified TE (M = 4.10, SD =
2.07): t(1,196) = 26.83, P < 0.001. In line with our hypotheses,
and similar to unspecified TEs, use of psychedelic substances
positively predicted having had an ETE: b = 0.46 (β = 0.10),
SE = 0.15, P = 0.002, 95% CI = [0.17; 0.75]. Controlling for
people’s desire or expectation of having an unspecified TE did
not meaningfully affect the association between psychedelic
substance use and ETEs: b = 0.38 (β = 0.09), SE = 0.14, P =
0.008, 95% CI = [0.10; 0.66].§
Quality of TEs. Participants at the various events were asked ad-
ditional questions about the quality of their TEs, if they had one,
which we analyzed exploratorily. Among the people who had a
Table 1. Sample demographics




Other (both/neither/fluid) 22 (1.8%)
Age
18 to 30 676 (55.2%)
31 to 40 285 (23.3%)
41 to 50 103 (8.4%)
51 to 60 89 (7.3%)
>60 33 (2.7%)
Religiosity: 1 (very low) to 7 (very high)
Low (1 and 2) 802 (65.5%)
Medium (3 to 5) 350 (28.6%)
High (6 and 7) 58 (4.7%)
Education (highest)
High school 75 (6.1%)
Some college 276 (22.5%)
2-y degree 169 (13.8%)
4-y degree 459 (37.5%)
Postgraduate or professional degree 233 (19.0%)
Political orientation: 1 (strongly liberal) to 7 (strongly conservative)
Liberal (1 and 2) 580 (47.3%)
Moderate (3 to 5) 550 (44.9%)
Conservative (6 and 7) 18 (1.5%)
§Specific desire for (n = 100) and expectation of having (n = 227) an ETE (as opposed to a
regular TE) were only assessed at one and two events, respectively. Inclusion of these
variables likewise did not affect statistical significance of the association between psy-
chedelic substance use and self-reported ETEs; b = 0.54 (β = 0.12), SE = 0.15, P < 0.001,
95% CI = [0.25; 0.84].





























self-reported TE, those who took psychedelic substances rated
their experience to be more positive (M = 5.44, SD = 1.49) than
those who had such an experience without taking psychedelic
substances (M = 4.87, SD = 1.64), t(544.5) = 5.04, P < 0.001, but
rated them as equally negative, t(508.71) = 0.40, P = 0.691. They
further described the extent of their experience as having been
greater (M = 4.05, SD = 1.58) than did nonusers of psychedelics
(M = 3.24, SD = 1.77), t(540.78) = 6.83, P < 0.001, and were
more likely to state that their moral values were changed as a
result of this experience (M = 3.19, SD = 1.92) than were people
who had these experiences without having taken psychedelics
(M = 2.62, SD = 1.86): t(554.05) = 4.59, P < 0.001. Descriptive
information regarding the quality of ETEs is provided in SI
Appendix, SOM I.
Positive mood.We further predicted that recent use of psychedelic
substances would predict user’s positive mood and that this in-
crease in positive mood would be mediated by self-reported TEs.
In line with this hypothesis, use of psychedelics predicted par-
ticipant’s positive mood: b = 0.14 (β = 0.08), SE = 0.06, P =
0.019, 95% CI = [0.02; 0.26].
Next, we investigated the hypothesized mediating role of TEs
in the relationship between substance use and positive mood. As
predicted, having had a TE predicted people’s positive mood:
b = 0.08 (β = 0.21), SE = 0.01, P < 0.001, 95% CI = [0.06; 0.10].
As a result, the indirect effect of psychedelic substance use on
positive mood via TEs was statistically significant, b = 0.05 (β =
0.03), SE = 0.01, P < 0.001, 95% CI = [0.03; 0.08], and rendered
the formerly significant direct effect of psychedelics use on posi-
tive mood (see above) nonsignificant: b = 0.08 (β = 0.05), SE =
0.06, P = 0.181, 95% CI = [−0.04; 0.20]. In other words, the re-
lationship between recent use of psychedelic substances and pos-
itive mood was indeed statistically mediated by self-reported TEs.
Social connectedness. In line with our preregistered hypotheses, we
found that—controlling for the use of other substances and de-
mographic variables—recent use of psychedelic substances sig-
nificantly and positively predicted social connectedness: b = 0.36
(β = 0.10), SE = 0.12, P = 0.003, 95% CI = [0.12; 0.60]. It
therefore seems as if psychedelic substance use may indeed
uniquely contribute to an increased perception of oneness or
connectedness with other human beings, regardless of the use of
other types of substances. While we did not preregister that so-
cial connectedness would mediate the effects of psychedelic
substance use on mood, we decided to explore this possibility in a
mediation analysis similar to the one we employed for TEs. We
found that social connectedness indeed predicted people’s pos-
itive mood: b = 0.11 (β = 0.23), SE = 0.01, P < 0.001, 95% CI =
[0.09; 0.14]. In addition, the indirect effect of psychedelic sub-
stance use on positive mood via social connectedness turned out
statistically significant, b = 0.04 (β = 0.02), SE = 0.01, P = 0.007,
95% CI = [0.01; 0.07], and reduced the direct effect to marginal
significance: b = 0.10 (β = 0.06), SE = 0.06, P = 0.089, 95% CI =
[−0.02; 0.22]. Based on these findings, we decided to further
explore the relationship between the various outcome variables
in the structural equation model below.
Very Recent vs. Moderately Recent Use of Psychedelics. Our ques-
tionnaire allowed us to differentiate between very recent (last
24 h) and moderately recent (the week prior) use of the various
substances. Of all users of psychedelic substances at the events
(n = 326), only 2.8% (n = 9) took a psychedelic substance both
within the past 24 h and in the week prior. A total of 69.6% (n =
227) only took them in the last 24 h, while 27.6% (n = 90) only
took them in the week prior.
In order to get more insight into how the recency of psyche-
delic experience moderated the observed psychological effects of
psychedelic substance use, we reran the analyses reported above
with a modification: instead of a single item indicating general
recent use of psychedelic substances, we included two variables
(both binary coded) representing very recent (i.e., in the past
24 h or current) or moderately recent (i.e., in the week prior) use
of psychedelic substances. This allowed us to test whether more
recent use of psychedelic substances would have stronger psy-
chological effects. Crucially, this analysis controls for potential
effects of a general willingness to take psychedelic substances on
our outcome variables. In other words, dispositional willingness
to ingest these substances may be associated with greater pro-
pensity to report TEs, greater social connectedness, or more
positive mood. One way we can account for this is by ensuring
that the results remain robust when controlling for expectations
and desires for TE (see above). However, an even stronger ap-
proach is to examine the temporal differences in these effects
within the substance-using population. This was possible because
the nature of our data collection procedure meant that partici-
pants completed our survey at a relatively random time point
after their psychedelic experience. This design therefore enabled
us to investigate the temporal dynamics of the psychological
effects of psychedelic substance use, that is, how the temporal
proximity (or salience) of such experiences factors into how their
effects unfold.
Overall, we found that very recent use of psychedelic sub-
stances, as compared to moderately recent use in the week prior,
was primarily responsible for predicting scores on the outcome
variables for which we found an association with general re-
cent psychedelic substance use. That is, self-reported TEs
(with and without controlling for expectations and desires),
ETEs, and psychological well-being were all significantly
predicted by use of psychedelic substances in the last 24 h, yet
not uniquely predicted by use of psychedelic substances in the
week prior (SI Appendix, SOM II, and Fig. 2). Comparing the
predictive power of moderately recent versus very recent use
of psychedelic substances on these outcome variables, we
found significantly larger predictive power of 24 h use of
psychedelics for self-reported TEs, Δb = 0.58 (β = 0.13), SE =
0.24, P = 0.017, 95% CI = [0.10; 1.06] (when controlling for
expectations and desires, Δb = 0.49 (β = 0.11), SE = 0.31, P =
0.031, 95% CI = [0.05; 0.94]), for ETEs, Δb = 0.49 (β = 0.10),
SE = 0.23, P = 0.035, 95% CI = [0.03; 0.97] (when controlling
for expectations and desires, Δb = 0.42 (β = 0.09), SE = 0.23,
P = 0.063, 95% CI = [−0.02; 0.87]), as well as for positive
mood, Δb = 0.27 (β = 0.13), SE = 0.10, P = 0.005, 95% CI =
[0.08; 0.46] (Fig. 2). Although we found that only very recent
(as opposed to moderately recent) use of psychedelics pre-
dicted feelings of social connectedness, there was no signifi-
cant difference in predictive power between the two
predictors. Detailed results for these and all other analyses
can be found in SI Appendix, SOM II.
Structural Equation Model. To consolidate the findings detailed
above and to investigate in more detail the relationships between
Fig. 1. Use of different classes of psychoactive substances across all events.
Numbers indicate the percentage of people who took any substance of the
respective class at some point during the week prior to data collection.
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substance use and psychological variables, we entered all rele-
vant variables into a structural equation model, testing for se-
quential mediation. More precisely, as predictors, we entered
the full set of variables representing moderately recent and
very recent use of each substance class, as well as the demo-
graphic variables age, gender, religiosity, education, and polit-
ical orientation. We designed the model to test how very recent
(vs. moderately recent) use of psychedelics would predict
participants’ positive mood via three indirect effects: (1) via
TEs (controlling for expectations and desires), (2) via social con-
nectedness alone, and (3) via TEs and connectedness in sequence
(Fig. 3).
Data from all mass gatherings were included in this SEM, with
missing values estimated using a full-information maximum
likelihood procedure. Given the comparably few degrees of
freedom, the model revealed good fit to the data; χ2 (4, n =
1,225) = 2.59, P = 0.628, CFI = 1.00, RMSEA = < 0.01, 90%
CIRMSEA = [0.00; 0.04].
Very recent psychedelic substance use. Confirming our previous
analyses, when controlling for expectations and desires, TEs
were positively predicted by very recent psychedelic substance
use: b = 0.78 (β = 0.15), SE = 0.15, P < 0.001, 95% CI = [0.48;
1.08]. Likewise, feelings of social connectedness were (margin-
ally significantly) predicted by very recent psychedelic substance
use, b = 0.24 (β = 0.06), SE = 0.13, P = 0.073, 95% CI = [−0.02;
0.50], yet more substantially by self-reported TEs, b = 0.11 (β =
0.14), SE = 0.02, P < 0.001, 95% CI = [0.07; 0.15], indicating that
both variables may function as sequential mediators.
Moderately recent psychedelic substance use. Although descriptively
pointing in the same direction, moderately recent psychedelic
substance use did not significantly predict any of the variables
included in the model. As we only found direct effects of very
recent use of psychedelic substances (i.e., within the last 24 h),
we focused on this variable for our mediation analyses.
Indirect effects/mediation. Focusing on our outcome variable of
positive mood, TEs by themselves (b = 0.07 [β = 0.18], SE = 0.01,
P < 0.001, 95% CI = [0.04; 0.09]) as well as social connectedness
(b = 0.10 [β = 0.21], SE = 0.01, P < 0.001, 95% CI = [0.08; 0.13]
both strongly predicted positive mood.
Testing for statistical mediation, three indirect effects of psy-
chedelic substance use on positive mood emerged: via TEs, b =
0.05 (β = 0.03), SE = 0.01, P < 0.001, 95% CI = [0.03; 0.08]; via
social connectedness, b = 0.02 (β = 0.01), SE = 0.01, P = 0.081,
95% CI = [0.00; 0.05]; and via both TEs and social connected-
ness in sequence, b = 0.01 (β < 0.01), SE < 0.01, P = 0.002, 95%
CI = [0.00; 0.01] (combined indirect effects, b = 0.09 (β = 0.04),
SE = 0.02, P < 0.001, 95% CI = [0.05; 0.13]). Controlling for
these indirect effects reduced the total effect of very recent
psychedelic substance use on psychological well-being (b = 0.20
[β = 0.10], SE = 0.07, P = 0.002, 95% CI = [0.07; 0.33]) to
marginal significance: b = 0.12 (β = 0.06), SE = 0.06, P = 0.067,
95% CI = [−0.01; 0.24].
In sum, we found that very recent use of psychedelic sub-
stances uniquely and positively predicted positive mood. These
associations were predominantly explained by participants’ self-
reported TEs and were robust to controlling for their ex-
pectations and desires for these experiences. To a lesser ex-
tent, these associations were also explained by increased
feelings of social connectedness, both as a function of TEs
or via other, unknown processes.{ As such, results indicate
that the relationship between psychedelic substance use
and psychological well-being is indeed statistically mediated
by two processes in sequence: TEs and feelings of social
connectedness.
Acute vs. Postacute Effects of Substances.One concern arising from
the present results is the possibility that the analyses we ran
confounded acute and postacute effects of psychedelic substance
use. In other words, while the acute subjective effects of psy-
chedelics taken more than 24 h ago (i.e., in the week prior) were
likely to have subsided by the time of data collection, certain
effects of some substances taken within the past 24 h (such as
those of LSD) may still have affected participants. This is due to
differences in absorption rates, half-lives, and subjective effects
of different psychedelic substances, as well as the exact time
when participants used them.
Therefore, when designing our study, we implemented several
measures to minimize the chances that any current (residual)
Fig. 2. Comparison of the effects of very recent vs. moderately recent use of psychedelics on the relevant outcome variables. All results control for the use of
other classes of psychoactive substances and demographic variables. Results for TEs and ETEs further control for expectations and desires for TEs. Error bars
represent 95% confidence intervals. Symbols above and below the coefficients indicate significant difference from zero; ***P < 0.001, **P < 0.01, *P < 0.05,
†P < 0.10; n. s., not significant.
{Results for the SEM including the sum scores for substance use can be found in SI
Appendix, SOM II. Including ETEs instead of TEs in the model produced highly similar
(and equally significant) results.





























intoxication would noticeably affect participants’ responses to
our questionnaire. First, we instructed experimenters to take
special care to only approach subjects who were not noticeably
intoxicated. Second, we collected data between 10 AM and
1 PM, reducing the likelihood that participants were under sub-
stantial influence of a substance. Third, we embedded a sobriety/
attention check item in our questionnaire (see above) and ex-
cluded participants who failed this check.
Finally, to validate that we indeed captured postacute,
rather than acute effects of psychedelic substances, we repli-
cated our main findings, excluding all participants (n = 47)
who reported being currently under the (residual) influence of
a psychedelic substance when completing the questionnaire.
This conservative test revealed effect sizes largely identical to
the full sample (see SI Appendix, SOM I and II, for detailed
results). In addition, although we were primarily concerned
with making sure to analyze postacute effects of psychedelic
substances in particular, we ran a second set of analyses ex-
cluding every participant who was, at the time of data col-
lection, under the influence of any substance (except for
nicotine, as specified in our preregistration). These analyses,
too, revealed results similar to the main analyses, indicating
that (residual) intoxication did indeed not play a major role in
responses to our questionnaire items.
TEs Due to Event Attendance Itself. Next, we considered the pos-
sibility that attending a multiday mass gathering may itself have
effects on TE, social connectedness, and mood, regardless of
substance use. This introduces a potential alternative explana-
tion for our findings: if time spent at a mass gathering is asso-
ciated with a higher likelihood of using psychedelics relative to
other substance classes (for instance, because participants prefer
to adjust to a new environment before taking psychedelics), and
time spent at a mass gathering also predicts TE, social connect-
edness, and mood, this could produce a spurious relationship
between psychedelic use and these outcome variables. We there-
fore reanalyzed our data including an additional covariate: the
number of days participants already spent at the event prior to
data collection (days at the event). On average, participants had
already spent 3 d (median) at the respective event when com-
pleting the questionnaires (with duration of attendance ranging
from 0 to 7 d). As suggested above, days at the event indeed
significantly predicted psychedelic substance use, (b = 0.04 [β =
0.15], SE < 0.01, P < 0.001, 95% CI = [0.02; 0.05]), and this re-
lationship was, in fact, about twice as strong as the corresponding
relationship with alcohol use (Δb = 0.02 [β = 0.09], SE < 0.01, P =
0.010, 95% CI = [0.01; 0.04]), or cannabinoid use (Δb = 0.02 [β =
0.08], SE < 0.01, P = 0.052, 95% CI = [−0.00; 0.03]). There-
fore, we tested whether this potential confound could indeed
account for our findings. Controlling for days at the event in
our main analyses produced similar results to the ones dis-
cussed above, with significant effects of (very) recent psyche-
delic substance use on TEs, ETEs, social connectedness, and
mood. Controlling for days at the event in the mediations and
the full SEM likewise produced results highly similar to the
main analyses (see SI Appendix, SOM II, for details). As such,
it seems as if event attendance itself does not explain the re-
lationship between psychedelic substance use and TEs, social
connectedness, or positive mood.
General Discussion
Data from a sample of more than 1,200 attendees across six mass
gatherings in two countries indicate that recent use of psyche-
delic substances positively predicted self-reported TEs, social
connectedness, and positive mood. Higher levels of self-reported TEs
were not explained by a stronger desire for, or a greater expectation
of having, such experiences. In addition, users of psychedelic
substances considered their TEs to be more positive and intense
and were more likely to report changes in their moral values
as a consequence of these experiences, compared with non-
users of psychedelics. Further, TEs and social connectedness sta-
tistically mediated the effects of very recent (within 24 h)
psychedelic substance use on positive mood. In all analyses, we
controlled for the use of other types of psychoactive substances as
well as a variety of demographic variables. Notably, use of eu-
phorics (such as MDMA) did not meaningfully predict our out-
come variables. Given that the effects of these substances are
prototypically associated with constructs such as social connect-
edness (hence their common classification as empathogens) or
positive mood, our findings with regard to psychedelics seem
especially relevant (see SI Appendix, SOM II, for detailed
results).
Our large dataset provides robust evidence that validates and
extends findings from a growing literature on the mood-enhancing
effects of psychoactive substances. Given that the psychedelic
experience is notoriously affected by environmental variables (2),
our laboratory-in-the-field approach allowed us to capture the
psychological effects of psychedelic substances in a setting where
people naturally use them. Collecting these data in the field also
allowed us to observe psychological variables in the immediate
aftermath of psychedelic substance use, in contrast to past studies
surveying retrospective reports of past use. This allowed us to
avoid relying on potentially incomplete or skewed recollections
of psychedelic experiences. Because our questions about sub-
stance use were embedded within a larger questionnaire about
social attitudes at mass gatherings, participants’ responses were
less likely to be affected by experimenter demand or precon-
ceived notions about the psychological effects of psychedelic
substances—a problem that can potentially arise in placebo-
controlled studies in which participants notice that they received
an active dose rather than a placebo or surveys that are explicitly
described as studying the effects of psychedelics. Finally, given
that participants completed our study at a relatively random time
point after their psychedelic experience, the fact that very recent
(past 24 h) psychedelic substance use had stronger psycho-
logical effects in our models hints at the importance of recency
of an experience in the effects of these substances on reported
TEs, feelings of social connectedness, and subsequent positive
mood.
Although effects of moderately recent psychedelic substance
use consistently pointed in the same direction as those of very
recent use, they did not reach statistical significance. This is
Fig. 3. Full structural equation model. Not displayed are control variables and other substance class predictors. Values represent standardized beta coef-
ficients. The stroke path represents the direct effects, with the value in parentheses indicating the total effect. ***P < 0.001, **P < 0.01, †P < 0.10.
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potentially due to a lack of statistical power as moderately recent
use (27.6%) was a less common occurrence among users of
psychedelics than very recent use (69.6%) was. However, al-
though they should be interpreted with caution, standardized
effect sizes suggest a decline in the effects over time. In other
words, feelings of transformation, social connectedness, or
enhanced mood may have partly regressed back toward
baseline in the days following the psychedelic experience,
rather than disappear entirely. Although on a smaller time-
scale and not in a clinical population, such a trend would
mirror the temporal effects of psychedelic substances on
people suffering from affective disorders (5). Yet, an even larger
sample or more sensitive measures would be necessary to make
precise statements about such temporal effects in the present
population.
Limitations
Our data have several limitations we should note. First, sub-
stance use was assessed via self report, which means we cannot
verify with certainty that participants actually took the substances
they indicated, nor can we pinpoint exactly which psychedelic
substances might be responsible for the observed effects. In
particular, participants may have been reluctant to disclose the use
of psychedelics and other illegal substances. We can address this
limitation in several ways. First, we designed our substance use
survey to minimize participants’ concerns about incriminating
themselves with affirmative responses, by including a legal exam-
ple in each substance category, and making this explicitly clear
to participants as well as the fact that their survey responses
were anonymous and confidential. Second, there is a common
perception of widespread substance use at the events we
studied, which reduces the possibility that participants would
have felt they violated a norm by ingesting psychoactive sub-
stances. Finally, we note that our findings are highly consistent
with placebo-controlled studies of the psychological effects of
psychedelic substance use in laboratory settings (e.g., refs. 19,
25, 27, and 31).
In addition, it is possible that one or multiple unassessed
variables that predict use of psychedelic but not other types of
substances likewise predicted some of our outcome variables.
That is, it is possible that a certain combination of personality
variables predicted both the use of psychedelic substances, as
well as the predisposition to have (or to report) TEs. To sidestep
this limitation, we compared very recent and moderately recent
use of psychedelic substances and found that effects on our
psychological variables were more pronounced for very recent
use. This shows that even among those participants who are
generally willing to use psychedelic substances, the recency of the
experience is a significant factor in predicting the respective
positive outcomes. Yet, the question remains why, when differ-
entiating moderately and very recent use of psychedelic sub-
stances, only very recent use significantly predicted our outcome
variables, given that past research established long-lasting
effects of psychedelics on similar variables (e.g., refs. 19 and
25). There are multiple potential reasons for this effect. First,
moderately recent use of psychedelics was a considerably less
common phenomenon (only 27.6% of psychedelics users took
a substance in the week prior) than was very recent use,
resulting in less statistical power to detect any effects on the
dependent variables. Second, as the salience of any experience
fades over time, one must expect a temporal decline in effects
caused by a psychoactive substance and therefore also expect
smaller effect sizes. Third, it is possible that—after an initial
postacute effect that is relatively short-lived—it requires more
time to fully integrate psychedelic experiences in order for
them to unfold into their potential long-term effects. Elabo-
rate follow-up studies will be necessary to fully explore this
possibility. Longitudinal studies with event attendees, however,
would likely require an even larger initial sample as one would need
to account for a substantial number of dropouts in the follow-
up analyses.
Further addressing the temporal dynamics of psychedelic
substance use and TE, future studies should try to assess more
precisely when psychedelic substance use and the experience of
transformation took place (although the latter was perceived to
be a rather gradual process by most participants; SI Appendix,
SOM I). This would allow us to investigate potential delays be-
tween substance use and TE, as well as help further control for
non–substance-induced TE due to the attendance of a mass
gathering itself.
A third limitation concerns the generalizability of our ob-
served effects. Attendees of certain cultural events, such as the
events at which we collected our data, as well as people who are
willing to use psychedelic substances in general, may be rather
different from the average person in terms of personality, po-
litical attitudes, or sociodemographic variables. As such, while
the results of our analyses may very well apply to the pro-
totypical user of psychedelic substances, we cannot make de-
finitive statements about how psychedelic substances affect
the average person. However, we note that our findings sur-
vive controlling for a variety of demographic variables that
past work has shown to predict a propensity to use psychedelic
substances (14, 36).
Finally, we note the correlational nature of our findings. The
methodology of the present research cannot entirely replace
laboratory studies, as the lack of random assignment prevents
causal inferences. Nevertheless, our data collection procedure
allowed us to directly compare the effects of psychedelics taken
in the past 24 h versus the past week. The fact that very recent
psychedelic use had stronger effects on TE, social connect-
edness, and positive mood suggests that the causal arrow may
run from substance use to affective outcomes, rather than the
other way around. However, causality can only be established
by means of experimental studies. Thus, in combination with
placebo-controlled laboratory studies, laboratory-in-the-field
studies have the potential to converge on a more complete
account of how psychedelic substances affect mood and social
relationships.
Conclusions
In sum, we provide evidence from a large sample that recent use
of psychedelic substances in a naturalistic setting is associated
with experiences of personal transformation, a sense of altered
moral values, increased feelings of social connectedness, and a
more positive mood. These effects were robust to controlling for
the use of other substances, a host of demographic variables, and
willingness to consume psychedelic substances in general. These
findings confirm, in a larger sample and a naturalistic setting,
previously observed positive effects of psychedelic substance use
in placebo-controlled experimental investigations in the labora-
tory and may have important implications for future research
into their therapeutic potential.
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